{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:57:24Z","timestamp":1720526244927},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T00:00:00Z","timestamp":1433894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00705-015-2482-3","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T03:54:19Z","timestamp":1433994859000},"page":"2009-2017","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment"],"prefix":"10.1007","volume":"160","author":[{"given":"Lucio","family":"Boglione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"2482_CR1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","volume":"327","author":"V Agnello","year":"1992","unstructured":"Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490\u20131495","journal-title":"N Engl J Med"},{"key":"2482_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0b013e3282f8afe2","volume":"17","author":"CE Alpers","year":"2008","unstructured":"Alpers CE, Smith KD (2008) Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens 17:243\u2013249","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2482_CR3","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2337\/diacare.28.10.2548","volume":"28","author":"A Antonelli","year":"2005","unstructured":"Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, Ferrannini E (2005) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28:2548\u20132550","journal-title":"Diabetes Care"},{"key":"2482_CR4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","volume":"256","author":"R Cavallo","year":"2009","unstructured":"Cavallo R, Roccatello D, Menegatti E, Naretto C, Napoli F, Baldovino S (2009) Rituximab in cryoglobulinemic peripheral neuropathy. J Neurol 256:1076\u20131082","journal-title":"J Neurol"},{"key":"2482_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","volume":"42","author":"MC Cid","year":"1999","unstructured":"Cid MC, Hernandez-Rodriguez J, Robert J, del Rio A, Casademont J, Coll-Vinent B, Grau JM, Kleinman HK, Urbano-Marquez A, Cardellach F (1999) Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum 42:1051\u20131055","journal-title":"Arthritis Rheum"},{"key":"2482_CR6","unstructured":"Corporation S-P (2007) Product information REBETOLw. Ribavirin capsules"},{"key":"2482_CR7","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1016\/S0168-8278(10)61193-2","volume":"52","author":"A D\u2019Avolio","year":"2010","unstructured":"D\u2019Avolio A, Ciancio A, Siccardi M, Baietto L, Simiele M, Patanella S, Marucco DA, Cariti G, Calcagno A, Sciandra M, Smedile A, De Rosa FG, Bonora S, Rizzetto M, Di Perri G (2010) SLC28A2 65C > T predict sustained virological response in patients with hepatitis C treated with interferon and ribavirin, considering all HCV genotype and genotype 1\/4. J Hepatol 52:S463\u2013S1463","journal-title":"J Hepatol"},{"key":"2482_CR8","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/hep.24636","volume":"54","author":"A D\u2019Avolio","year":"2011","unstructured":"D\u2019Avolio A, Ciancio A, Siccardi M, Baietto L, Simiele M, Cariti G, Calcagno A, Smedile A, Cusato J, Bonora S, Rizzetto M, Di Perri G (2011) Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon\/ribavirin treatment in patients infected with hepatitis C virus genotype 1\/4. Hepatology 54:2279","journal-title":"Hepatology"},{"key":"2482_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/FTD.0b013e318272e55a","volume":"34","author":"A D\u2019Avolio","year":"2012","unstructured":"D\u2019Avolio A, Ciancio A, Siccardi M, Smedile A, Simiele M, Cusato J, Baietto L, Marucco DA, Cariti G, Calcagno A, de Requena DG, Sciandra M, Troshina G, Caviglia GP, Bonora S, Rizzetto M, Di Perri G (2012) Negative predictive value of IL28B, SLC28A2 and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG\/IFN-RBV treatment. Ther Drug Monit 34:722\u2013728","journal-title":"Ther Drug Monit"},{"key":"2482_CR10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12072-011-9303-x","volume":"6","author":"HR Khayat El","year":"2011","unstructured":"El Khayat HR, Fouad YM, Ahmad EA, El Amin H, Ismael F, Rizk A (2011) Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment. Hepatol Int 6:606\u2013612","journal-title":"Hepatol Int"},{"key":"2482_CR11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jmv.23562","volume":"85","author":"F Fabrizi","year":"2013","unstructured":"Fabrizi F, Dixit V, Messa P (2013) Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies. J Med Virol 85:1019\u20131027","journal-title":"J Med Virol"},{"key":"2482_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","volume":"33","author":"C Ferri","year":"2004","unstructured":"Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355\u2013374","journal-title":"Semin Arthritis Rheum"},{"key":"2482_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399\u2013401","journal-title":"Nature"},{"key":"2482_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1529-8027.2002.02007.x","volume":"7","author":"F Gemignani","year":"2002","unstructured":"Gemignani F, Melli G, Inglese C, Marbini A (2002) Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients. J Peripher Nerv Syst 7:59\u201364","journal-title":"J Peripher Nerv Syst"},{"key":"2482_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0163-4453(98)80022-4","volume":"36","author":"AC Gordon","year":"1998","unstructured":"Gordon AC, Edgar JD, Finch RG (1998) Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect 36:229\u2013230","journal-title":"J Infect"},{"key":"2482_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","volume":"139","author":"M Honda","year":"2010","unstructured":"Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Nakamura M, Shirasaki T, Horimoto K, Tanaka Y, Tokunaga K, Mizokami M, Kaneko S (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139:499\u2013509","journal-title":"Gastroenterology"},{"key":"2482_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/07853899908995902","volume":"31","author":"JP Horcajada","year":"1999","unstructured":"Horcajada JP, Garcia-Bengoechea M, Cilla G, Etxaniz P, Cuadrado E, Arenas JI (1999) Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 31:352\u2013358","journal-title":"Ann Med"},{"key":"2482_CR18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cgh.2010.08.026","volume":"8","author":"IM Jacobson","year":"2010","unstructured":"Jacobson IM, Cacoub P, Dal Maso L, Harrison SA, Younossi ZM (2010) Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol 8:1017\u20131029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2482_CR19","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s10620-006-9355-2","volume":"52","author":"S Joshi","year":"2007","unstructured":"Joshi S, Kuczynski M, Heathcote EJ (2007) Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia. Dig Dis Sci 52:2410\u20132417","journal-title":"Dig Dis Sci"},{"key":"2482_CR20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jmv.2130","volume":"66","author":"N Leone","year":"2002","unstructured":"Leone N, Pellicano R, Ariata Maiocco I, Modena V, Marietti G, Rizzetto M, Ponzetto A (2002) Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol 66:200\u2013203","journal-title":"J Med Virol"},{"key":"2482_CR21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","volume":"106","author":"F Lunel","year":"1994","unstructured":"Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC et al (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291\u20131300","journal-title":"Gastroenterology"},{"key":"2482_CR22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.gene.2012.10.030","volume":"513","author":"Y Luo","year":"2012","unstructured":"Luo Y, Jin C, Ling Z, Mou X, Zhang Q, Xiang C (2012) Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF\/RBV therapy using systematic meta-analysis. Gene 513:292\u2013296","journal-title":"Gene"},{"key":"2482_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jgh.12475","volume":"29","author":"K Matsuura","year":"2014","unstructured":"Matsuura K, Watanabe T, Tanaka Y (2014) Role of IL28B for chronic hepatitis C treatment toward personalized medicine. J Gastroenterol Hepatol 29:241\u2013249","journal-title":"J Gastroenterol Hepatol"},{"key":"2482_CR24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2009.185074","volume":"58","author":"R Moucari","year":"2009","unstructured":"Moucari R, Ripault MP, Martinot-Peignoux M, Voitot H, Cardoso AC, Stern C, Boyer N, Maylin S, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P (2009) Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut 58:1662\u20131669","journal-title":"Gut"},{"key":"2482_CR25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1096-9071(199801)54:1<20::AID-JMV4>3.0.CO;2-R","volume":"54","author":"QT Nguyen","year":"1998","unstructured":"Nguyen QT, Leruez-Ville M, Ferriere F, Cohen P, Roulot-Marullo D, Coste T, Deny P, Guillevin L (1998) Hepatitis C virus genotypes implicated in mixed cryoglobulinemia. J Med Virol 54:20\u201325","journal-title":"J Med Virol"},{"key":"2482_CR26","unstructured":"Pharmaceuticals R (2007) Product information COPEGUSw. Ribavirin tablets"},{"key":"2482_CR27","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1111\/jvh.12017","volume":"20","author":"A Piluso","year":"2013","unstructured":"Piluso A, Giannini C, Fognani E, Gragnani L, Caini P, Monti M, Petrarca A, Ranieri J, Urraro T, Triboli E, Laffi G, Zignego AL (2013) Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study. J Viral Hepat 20:e107\u2013e114","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"2482_CR28","doi-asserted-by":"crossref","first-page":"s64","DOI":"10.1177\/096120330501400114","volume":"14","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Font J (2005) Mycophenolate mofetil in patients with hepatitis C virus infection. Lupus 14(Suppl 1):s64\u2013s72","journal-title":"Lupus"},{"key":"2482_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J (2005) Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84:81\u201389","journal-title":"Medicine (Baltimore)"},{"key":"2482_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","volume":"49","author":"D Roccatello","year":"2007","unstructured":"Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, Di Belgiojoso GB, Comotti C, Quarenghi MI (2007) Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49:69\u201382","journal-title":"Am J Kidney Dis"},{"key":"2482_CR31","unstructured":"Roche Pharmaceuticals N, NJ (2004) Pegasys (package insert)"},{"key":"2482_CR32","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","volume":"54","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P (2006) Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 54:3696\u20133706","journal-title":"Arthritis Rheum"},{"key":"2482_CR33","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","volume":"166","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Sellam J, Ghillani-Dalbin P, Crecel R, Piette JC, Cacoub P (2006) Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166:2101\u20132108","journal-title":"Arch Intern Med"},{"key":"2482_CR34","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","volume":"46","author":"D Saadoun","year":"2007","unstructured":"Saadoun D, Landau DA, Calabrese LH, Cacoub PP (2007) Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 46:1234\u20131242","journal-title":"Rheumatology (Oxford)"},{"key":"2482_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/kel425","volume":"46","author":"D Sansonno","year":"2007","unstructured":"Sansonno D, Carbone A, De Re V, Dammacco F (2007) Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46:572\u2013578","journal-title":"Rheumatology (Oxford)"},{"key":"2482_CR36","unstructured":"Schering-Plough Corporation, Kenilworth N (2003) PEG-Intron (package insert)"},{"issue":"Suppl 2","key":"2482_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1478-3231.2008.01952.x","volume":"29","author":"L Serfaty","year":"2009","unstructured":"Serfaty L, Capeau J (2009) Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int 29(Suppl 2):13\u201325","journal-title":"Liver Int"},{"issue":"344\u2013350","key":"2482_CR38","first-page":"e342","volume":"9","author":"AF Stattermayer","year":"2011","unstructured":"Stattermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, Zinober K, Datz C, Maieron A, Dulic-Lakovic E, Kessler HH, Steindl-Munda P, Strasser M, Krall C, Ferenci P (2011) Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin Gastroenterol Hepatol 9(344\u2013350):e342","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2482_CR39","first-page":"1847","volume":"90","author":"K Tanaka","year":"1995","unstructured":"Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakumu S (1995) Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 90:1847\u20131852","journal-title":"Am J Gastroenterol"},{"key":"2482_CR40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","volume":"80","author":"O Trejo","year":"2001","unstructured":"Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, de la Red G, Cervera R, Font J, Ingelmo M (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80:252\u2013262","journal-title":"Medicine (Baltimore)"},{"key":"2482_CR41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","volume":"46","author":"D Vassilopoulos","year":"2002","unstructured":"Vassilopoulos D, Calabrese LH (2002) Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 46:585\u2013597","journal-title":"Arthritis Rheum"},{"key":"2482_CR42","unstructured":"WHO (2013) HCV. World Health Organization. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/"},{"key":"2482_CR43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","volume":"39","author":"AL Zignego","year":"2007","unstructured":"Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39:2\u201317","journal-title":"Dig Liver Dis"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2482-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-015-2482-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2482-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:58:56Z","timestamp":1559105936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-015-2482-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,10]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2482"],"URL":"https:\/\/doi.org\/10.1007\/s00705-015-2482-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,10]]}}}